Testing effectiveness (Phase 2)Ended earlyNCT03600467
What this trial is testing
Activity of Seviteronel in Patients With Androgen Receptor (AR)-Positive Glioblastoma
Who this might be right for
Solid TumorAndrogen Receptor Gene Overexpression
St Vincent's Hospital, Sydney 4